Document Detail

The influence of hypotensive drugs on the taste sensitivity in patients with primary hypertension.
MedLine Citation:
PMID:  22574515     Owner:  NLM     Status:  In-Process    
Numerous hypotensive drugs result in decreasing the taste sensitivity or total loss of taste perception. The aim of this study was to evaluate the influence of selected groups of hypotensive drugs used in combined treatment of the taste sensitivity in patients suffering from primary arterial hypertension. The study was conducted in a group of 84 patients aged 30-60, including 43 women and 41 men. The patients were divided into four groups depending on the applied combined treatment including the following treatment regimes: diuretic + beta-blocker, diuretic + beta-blocker + ACE-I, ACE-I + diuretic, ACE-I + diuretic + calcium channel blocker. The study involved also control group of 20 healthy people (without medications) aged 30-60, including 10 women and 10 men. Taste sensitivity was evaluated by two methods: chemosensory and electrogustometric. Chemosensory method was used to asses the sensitivity to salt and sweet tastes with the use of increasing concentrations of saccharose water solutions (0.012-0.041 mmol/L) and water solutions of sodium chloride (0.008-0.068 mmol/L). Electrogustometric thresholds of taste sensitivity were established with electrogustometer. The minimal intensity of the current, which stimulates nerve endings of the taste stimuli-transmitting nerves was determined in two areas of the tongue: at the apex and at the sides. By two different methods of evaluation it was shown that the analyzed groups of hypotensive drugs affect the taste sensitivity of the patients. It was observed that healthy people had higher taste sensitivity than patients. Introducing ACE-I into combined therapy significantly reduced the electrogustometric sensitivity in patients.
Joanna Suliburska; Grazyna Duda; Danuta Pupek-Musialik
Related Documents :
3698245 - Ventricular tachycardia in a young population without overt heart disease.
22699805 - Effects of beta-blocker use on volume status in hemodialysis patients.
18091535 - Characteristics and outcomes of patients receiving a medical emergency team review for ...
1553895 - Bepridil therapy: guidelines for patient selection and monitoring of therapy.
2990195 - Chronic syndrome of inappropriate secretion of antidiuretic hormone in childhood.
15925555 - Ultrasound guidance in the placement of a percutaneous endoscopic gastrostomy (peg): an...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta poloniae pharmaceutica     Volume:  69     ISSN:  0001-6837     ISO Abbreviation:  Acta Pol Pharm     Publication Date:    2012 Jan-Feb
Date Detail:
Created Date:  2012-05-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985167R     Medline TA:  Acta Pol Pharm     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  121-7     Citation Subset:  IM    
Department of Human Nutrition and Hygiene, Life Sciences University in Poznan, Wojska Polskiego 31, 60-624 Poznań, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bone remodeling after administration of proton pump (H+/K+-ATPase) inhibitors and alendronate in ova...
Next Document:  Inhibitory activity of fermented milk with Lactobacillus casei strain Shirota against common multidr...